Medical Treatment Consent Form (UAE)

A Medical Treatment Consent Form in the United Arab Emirates is a formal written document by which a patient — or a guardian or legal representative where the patient is a minor or lacks legal capacity — gives informed, voluntary, and documented consent to a healthcare provider to carry out a specified medical procedure or course of treatment. The document is a legal and ethical requirement in the UAE under Federal Law No. 4 of 2016 on Medical Liability, which imposes a direct duty on healthcare facilities licensed by the Dubai Health Authority (DHA), the Department of Health — Abu Dhabi (DOH), or the Ministry of Health and Prevention (MOHAP) to obtain written consent from patients before performing any non-emergency medical procedure.

The consent form is not merely a bureaucratic requirement; it is evidence that the patient received adequate information and exercised an autonomous choice. The Federal Medical Liability Law and the implementing standards of the DHA, the DOH, and the MOHAP all require that consent be: informed (the patient received a clear explanation of the procedure, its risks, its benefits, and the alternatives); voluntary (no coercion or undue influence); competent (the patient or representative has the legal and mental capacity to decide); and documented in writing for any invasive or high-risk procedure.

The UAE Personal Data Protection Law (Federal Decree-Law No. 45 of 2021), administered by the UAE Data Office, also applies to the medical consent form. Health data is classified as sensitive personal data under the PDPL, and the healthcare provider must have a lawful basis for processing it, including the patient's explicit consent where the data is to be used for purposes beyond direct treatment, such as research, training, or quality improvement. The consent form therefore addresses both the clinical consent to treatment and, where relevant, the data consent for secondary uses.

The Dubai Health Authority's Patient Rights Charter and the Abu Dhabi Health Information Centre (HAAD, now integrated into the DOH) standards specify the minimum information that must be given to the patient before consent is sought: the diagnosis, the proposed treatment and its purpose, the material risks and likely complications, the available alternatives, and the consequences of declining treatment. Failure to provide this information and obtain valid consent may expose the healthcare facility and the treating clinician to liability under the Federal Medical Liability Law, and the Dubai Healthcare City Authority (DHCA) and the Abu Dhabi Judicial Department enforce these standards in medical liability proceedings.

For minors under 18 years of age, the UAE law on personal status and guardianship — now updated by Federal Decree-Law No. 41 of 2024 on Personal Status — requires the consent of a parent or legal guardian. For adult patients who lack mental capacity, the guardian appointed under UAE law or a close relative recognised by the treating facility may consent on the patient's behalf. The treating facility must document the basis of the guardian's authority before proceeding.

A Medical Treatment Consent Form in the United Arab Emirates is needed before any non-emergency medical procedure and in a range of clinical and administrative situations governed by the Federal Medical Liability Law (Federal Law No. 4 of 2016) and the standards of the Dubai Health Authority, the Department of Health — Abu Dhabi, and the Ministry of Health and Prevention.

Surgical procedures require a written consent form in every case where a licensed UAE healthcare facility performs an invasive procedure under local, regional, or general anaesthesia. Hospitals and day-surgery centres licensed by the DHA, the DOH, or the MOHAP are required to have a signed consent form in the patient's file before the operating theatre is entered. The consent must be specific to the procedure described; a general blanket consent at admission does not satisfy the Federal Medical Liability Law for individual procedures.

Diagnostic procedures with material risk — such as cardiac catheterisation, bone marrow biopsy, or invasive radiology — require a separate consent form identifying the specific investigation, the rationale, and the material risks, consistent with the DHA clinical governance standards and the DOH patient safety framework.

Anaesthesia consent is required separately from the surgical consent form in most UAE facilities, because the risks of anaesthesia are distinct from the risks of the surgical procedure. The anaesthetist has an independent duty to explain and obtain consent for the type of anaesthesia proposed.

Medical research and clinical trials conducted in UAE facilities licensed by the MOHAP require consent that complies with both the Federal Medical Liability Law and the PDPL (Federal Decree-Law No. 45 of 2021), because research involves both clinical risk and the processing of health data for purposes beyond direct treatment. The UAE Data Office requires explicit consent for the use of sensitive personal data in research.

Fertility treatment, gender-affirming care, cosmetic procedures, and other elective treatments at DHA or MOHAP licensed clinics require detailed written consent that addresses the elective nature of the procedure and the realistic expectations of outcome.

Minor patients undergoing any significant medical procedure require parental or guardian consent. Schools, nurseries, and sports clubs registered in the UAE also use abbreviated medical consent forms to authorise routine first-aid treatment and to permit emergency hospital treatment when parents cannot be reached.

A valid Medical Treatment Consent Form in the United Arab Emirates must contain specified elements to satisfy Federal Law No. 4 of 2016 on Medical Liability, the patient rights standards of the Dubai Health Authority, the Department of Health — Abu Dhabi, and the Ministry of Health and Prevention, and the data protection requirements of the Personal Data Protection Law (Federal Decree-Law No. 45 of 2021). The forms-legal.com UAE Medical Treatment Consent Form template addresses each of these requirements.

Patient identification must include the patient's full legal name, date of birth, Emirates ID number or passport number, and nationality. For minors or incapacitated patients, the form must also identify the guardian or legal representative by name, relationship to the patient, and Emirates ID or passport number. The treating facility verifies these details against original identity documents at the time of admission.

Healthcare provider identification names the licensed facility — hospital, clinic, or day-surgery centre — and the treating clinician responsible for the procedure. The DHA and the DOH require the clinician's name and speciality to appear on the consent form, because the patient's consent is personal to the identified clinician and procedure.

Proposed treatment description must set out the proposed procedure in language the patient can understand, identifying the procedure by its clinical name and a plain-language description of what it involves. A vague description such as 'abdominal surgery' is insufficient; the form must identify the specific procedure, the body part affected, and the technique proposed.

Risks and alternatives: the Federal Medical Liability Law requires that the patient be informed of the material risks of the procedure — those risks that a reasonable patient would regard as significant — and of available alternatives, including the option of no treatment. The treating clinician explains these verbally; the consent form confirms in writing that the explanation was given and understood.

Informed and voluntary consent: the form must contain a statement by the patient or guardian that the consent is freely given without coercion, that questions were answered satisfactorily, and that the right to withdraw consent before the procedure commences has been explained and understood.

Data consent under the PDPL: where the patient's health data may be used for research, training, or quality improvement, a separate consent must be obtained under the Personal Data Protection Law (Federal Decree-Law No. 45 of 2021), which classifies health data as sensitive. The consent must be explicit and specific to the intended use.

Date and signature: the date of consent in DD/MM/YYYY format, and the patient's or guardian's signature, witnessed by a facility representative.

Completing a Medical Treatment Consent Form for use in a UAE healthcare facility requires both the treating clinician and the patient or guardian to participate.

Step one: complete the patient's details. Enter the patient's full legal name exactly as shown on the Emirates ID or passport, the date of birth in DD/MM/YYYY format, the Emirates ID number or passport number, and nationality. Where the patient is a minor or lacks capacity, complete the guardian section with the guardian's full name, relationship, and Emirates ID or passport number. The facility will verify these details against original documents.

Step two: identify the healthcare provider. Enter the full name of the licensed facility — hospital, clinic, or surgical centre — and the name and speciality of the treating clinician. For DHA-licensed facilities, the clinician's DHA licence number should also be recorded for clinical governance purposes.

Step three: describe the proposed treatment. Write out the procedure in clear language that the patient can understand: include the clinical name and a plain-language explanation of what the procedure involves, the body part, and the technique. Avoid abbreviations that the patient may not recognise.

Step four: conduct the information session. The treating clinician explains in the patient's language: (a) the purpose and expected benefits; (b) the material risks and likely complications; (c) the available alternatives; and (d) what will happen if the patient declines treatment. The clinician answers all questions before asking for signature. This step fulfils the informed consent requirement of the Federal Medical Liability Law (Federal Law No. 4 of 2016) and the DHA and DOH standards.

Step five: address data consent. Ask the patient whether they agree to anonymised health data being used for research or teaching. Mark 'Yes' or 'No' on the form. Where consent is given, it must comply with the Personal Data Protection Law (Federal Decree-Law No. 45 of 2021).

Step six: set the consent date in DD/MM/YYYY format. Consent must be obtained before the procedure, not during it or after the patient has been sedated.

Step seven: obtain the signature. The patient or guardian signs in the presence of the facility representative, who also signs as a witness. The signed original is retained in the patient's medical file. Download the form as PDF or Word via forms-legal.com.

Medical treatment consent in the United Arab Emirates is governed primarily by Federal Law No. 4 of 2016 on Medical Liability, which applies to all healthcare practitioners and facilities licensed by the DHA, the DOH, or the MOHAP. Article 10 of the Federal Medical Liability Law requires healthcare providers to obtain the patient's written informed consent before performing any medical procedure, except in life-threatening emergencies where consent cannot be obtained in time and delay would endanger the patient's life.

The DHA Patient Rights Charter, the DOH Patient Rights and Responsibilities policy, and the MOHAP standards each specify the information that must be disclosed to the patient: the diagnosis, the proposed treatment, the material risks, the alternatives, and the consequences of refusal. Failure to obtain valid informed consent — or obtaining consent without adequate disclosure — may constitute a breach of the duty of care under Federal Law No. 4 of 2016, exposing the practitioner and facility to professional liability proceedings before the DHA Medical Liability Committee, the DOH Medical Review Panel, or the civil courts.

For minor patients, consent is given by a parent or legal guardian under the personal status and guardianship rules updated by Federal Decree-Law No. 41 of 2024. For adult patients who lack mental capacity, the facility should obtain consent from a court-appointed guardian or, where time is critical, from the closest available relative and document the circumstances.

The Personal Data Protection Law (Federal Decree-Law No. 45 of 2021) classifies health data as sensitive personal data. Processing health data beyond direct clinical treatment requires the patient's explicit consent under the PDPL, and the data must be processed in accordance with the purpose limitation, security, and retention requirements of that law. The UAE Data Office supervises PDPL compliance. Cross-border transfer of patient health data outside the UAE requires the additional safeguards set out in the PDPL.

Electronic consent forms are accepted in UAE healthcare facilities that use approved electronic health record (EHR) systems licensed by the relevant authority, provided the system securely authenticates the signatory and creates an immutable record of the consent and the date it was given.

Errors in medical treatment consent in the United Arab Emirates can expose both the healthcare provider and the patient to risk and may delay necessary treatment.

The first mistake is obtaining blanket admission consent in place of procedure-specific consent. A general consent signed at the hospital admission desk does not satisfy the Federal Medical Liability Law (Federal Law No. 4 of 2016) for individual invasive or high-risk procedures. Each significant procedure requires its own consent form identifying the specific treatment.

The second mistake is failing to disclose material risks. The DHA, DOH, and MOHAP standards require the patient to be informed of all risks that a reasonable patient would consider significant. Omitting a commonly known risk — for example, infection after surgery, or the risk of anaesthetic complications — may constitute inadequate consent and expose the clinician to liability.

The third mistake is obtaining consent from the wrong person. Where the patient is a minor, consent must come from a parent or legal guardian, not from an older sibling or friend. For adult patients who lack capacity, consent must be obtained from the legally recognised guardian. An undertaking signed by an unauthorised person does not satisfy the Federal Medical Liability Law.

The fourth mistake is signing the consent form after sedation or pre-medication. Consent must be obtained while the patient is fully alert and capable of understanding the information. A form signed by a patient who has already received sedation is voidable on grounds of incapacity.

The fifth mistake is failing to address the Personal Data Protection Law (Federal Decree-Law No. 45 of 2021) where health data will be used for research or training. Using patient data without explicit PDPL consent exposes the facility to regulatory enforcement by the UAE Data Office.

The sixth mistake is storing the signed consent form inadequately. The DHA, DOH, and MOHAP standards require consent forms to be retained in the patient's medical record for specified periods. A facility that cannot produce the signed consent form in a medical liability dispute is at a significant evidentiary disadvantage before the DHA Medical Liability Committee or the Abu Dhabi Judicial Department.